Scancell Holdings (LSE:SCLP) Days Payable : 0.00 (As of Oct. 2023)

View and export this data going back to 2010. Start your Free Trial

What is Scancell Holdings Days Payable?

Scancell Holdings's average Accounts Payable for the six months ended in Oct. 2023 was £1.49 Mil. Scancell Holdings's Cost of Goods Sold for the six months ended in Oct. 2023 was £0.00 Mil.

The historical rank and industry rank for Scancell Holdings's Days Payable or its related term are showing as below:

LSE:SCLP' s Days Payable Range Over the Past 10 Years
Min: 652.83 Med: 652.83 Max: 652.83
Current: 652.83

During the past 13 years, Scancell Holdings's highest Days Payable was 652.83. The lowest was 652.83. And the median was 652.83.

LSE:SCLP's Days Payable is ranked better than
79.83% of 714 companies
in the Biotechnology industry
Industry Median: 146.16 vs LSE:SCLP: 652.83

Scancell Holdings's Days Payable declined from Oct. 2022 (535.33) to Oct. 2023 (0.00). It may suggest that Scancell Holdings accelerated paying its suppliers.

Scancell Holdings Days Payable Historical Data

The historical data trend for Scancell Holdings's Days Payable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Scancell Holdings Days Payable Chart

Scancell Holdings Annual Data

Trend

Apr14

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Days Payable

Get a 7-Day Free Trial

652.83

Scancell Holdings Semi-Annual Data
	Apr14	Oct14	Apr15	Oct15	Apr16	Oct16	Apr17	Oct17	Apr18	Oct18	Apr19	Oct19	Apr20	Oct20	Apr21	Oct21	Apr22	Oct22	Apr23	Oct23
Days Payable	Get a 7-Day Free Trial															-	-	535.33	-	-

Competitive Comparison of Scancell Holdings's Days Payable

For the Biotechnology subindustry, Scancell Holdings's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Scancell Holdings's Days Payable Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Scancell Holdings's Days Payable distribution charts can be found below:

* The bar in red indicates where Scancell Holdings's Days Payable falls into.

Scancell Holdings Days Payable Calculation

Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.

Scancell Holdings's Days Payable for the fiscal year that ended in Apr. 2023 is calculated as

	Days Payable (A: Apr. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (A: Apr. 2022 )	+	Accounts Payable (A: Apr. 2023 ))	/	count )	/	Cost of Goods Sold (A: Apr. 2023 )	*	Days in Period
=	( (0.569	+	1.309)	/	2 )	/	0.525	*	365
=	0.939					/	0.525	*	365
=	652.83

Scancell Holdings's Days Payable for the quarter that ended in Oct. 2023 is calculated as:

	Days Payable (Q: Oct. 2023 )
=	Average Accounts Payable					/	Cost of Goods Sold	*	Days in Period
=	( (Accounts Payable (Q: Apr. 2023 )	+	Accounts Payable (Q: Oct. 2023 ))	/	count )	/	Cost of Goods Sold (Q: Oct. 2023 )	*	Days in Period
=	( (1.309	+	1.664)	/	2 )	/	0	*	365 / 2
=	1.4865					/	0	*	365 / 2
=	N/A

Scancell Holdings Days Payable Related Terms

Thank you for viewing the detailed overview of Scancell Holdings's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.

Scancell Holdings (LSE:SCLP) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Scancell Holdings PLC (LSE:SCLP) » Definitions » Days Payable

Comparable Companies

Traded in Other Exchanges

SCLP.GB:UK SCP:Germany

Address

Sanders Road, Unit 202, Bellhouse Building, Oxford Science Park, Oxford, GBR, OX4 4GD

Website

https://www.scancell.co.uk

Scancell Holdings PLC is engaged in the discovery and development of novel vaccines for the treatment of cancer. The company is exploiting the unrivalled potential of the immune system to seek out and destroy cancer using two proprietary immuno-oncology platforms: ImmunoBody and Moditope. Its potent innovative DNA-based ImmunoBody therapies generate ultra-high avidity T cell responses that target and eliminate cancerous tumors. Its Moditope platform technology overcomes the immune suppression induced by tumors themselves, allowing activated T cells to seek out and kill tumor cells that would otherwise be hidden from the immune system.

Scancell Holdings (LSE:SCLP) Headlines

No Headlines